Literature DB >> 32660962

Strategies to Reduce Rehospitalization in Patients with CKD and Kidney Failure.

Simit Doshi1, Jay B Wish2.   

Abstract

Readmissions in patients with nondialysis-dependent CKD and kidney failure are common and are associated with significant morbidity, mortality, and economic consequences. In 2013, the Centers for Medicare and Medicaid Services implemented the Hospital Readmissions Reduction Program in an attempt to reduce high hospitalization-associated costs. Up to 50% of all readmissions are deemed avoidable and present an opportunity for intervention. We describe factors that are specific to the patient, the index hospitalization, and underlying conditions that help identify the "high-risk" patient. Early follow-up care, developing volume management strategies, optimizing nutrition, obtaining palliative care consultations for seriously ill patients during hospitalization and conducting goals-of-care discussions with them, instituting systematic advance care planning during outpatient visits to avoid unwanted hospitalizations and intensive treatment at the end of life, and developing protocols for patients with incident or prevalent cardiovascular conditions may help prevent avoidable readmissions in patients with kidney disease.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  Chronic; Hospital Costs; Medicaid; Medicare; Outpatients; Palliative Care; Patient Care Planning; Patient Readmission; Renal Insufficiency; chronic kidney disease; hospitalization; kidney failure; rehospitalization

Mesh:

Year:  2020        PMID: 32660962      PMCID: PMC7863646          DOI: 10.2215/CJN.02300220

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  50 in total

1.  Infection-related hospitalization rates in pediatric versus adult patients with end-stage renal disease in the United States.

Authors:  Blanche M Chavers; Craig A Solid; David T Gilbertson; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2007-01-24       Impact factor: 10.121

2.  Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis.

Authors:  Lorien S Dalrymple; Yi Mu; Patrick S Romano; Danh V Nguyen; Glenn M Chertow; Cynthia Delgado; Barbara Grimes; George A Kaysen; Kirsten L Johansen
Journal:  Am J Kidney Dis       Date:  2015-01-30       Impact factor: 8.860

Review 3.  Proportion of hospital readmissions deemed avoidable: a systematic review.

Authors:  Carl van Walraven; Carol Bennett; Alison Jennings; Peter C Austin; Alan J Forster
Journal:  CMAJ       Date:  2011-03-28       Impact factor: 8.262

4.  Risks of subsequent hospitalization and death in patients with kidney disease.

Authors:  Kenn B Daratha; Robert A Short; Cynthia F Corbett; Michael E Ring; Radica Alicic; Randall Choka; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 8.237

Review 5.  Reducing hospital readmissions in patients with end-stage kidney disease.

Authors:  Anna T Mathew; Giovanni F M Strippoli; Marinella Ruospo; Steven Fishbane
Journal:  Kidney Int       Date:  2015-10-14       Impact factor: 10.612

6.  Infection-related hospitalizations in older patients with ESRD.

Authors:  Lorien S Dalrymple; Kirsten L Johansen; Glenn M Chertow; Su-Chun Cheng; Barbara Grimes; Ellen B Gold; George A Kaysen
Journal:  Am J Kidney Dis       Date:  2010-07-08       Impact factor: 8.860

7.  Adverse safety events in chronic kidney disease: the frequency of "multiple hits".

Authors:  Erica Chapin; Min Zhan; Van Doren Hsu; Stephen L Seliger; Loreen D Walker; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

8.  Potentially preventable hospitalization as a complication of CKD: a cohort study.

Authors:  Natasha Wiebe; Scott W Klarenbach; G Michael Allan; Braden J Manns; Rick Pelletier; Matthew T James; Aminu Bello; Brenda R Hemmelgarn; Marcello Tonelli
Journal:  Am J Kidney Dis       Date:  2014-04-13       Impact factor: 8.860

9.  All-cause costs increase exponentially with increased chronic kidney disease stage.

Authors:  Ladan Golestaneh; Paula J Alvarez; Nancy L Reaven; Susan E Funk; Karen J McGaughey; Alain Romero; Melanie S Brenner; Macaulay Onuigbo
Journal:  Am J Manag Care       Date:  2017-06       Impact factor: 2.229

10.  Causes and patterns of readmissions in patients with common comorbidities: retrospective cohort study.

Authors:  Jacques Donzé; Stuart Lipsitz; David W Bates; Jeffrey L Schnipper
Journal:  BMJ       Date:  2013-12-16
View more
  4 in total

1.  Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease.

Authors:  Dae Yong Park; Seokyung An; Jonathan M Hanna; Stephen Y Wang; Ana S Cruz-Solbes; Ajar Kochar; Angela M Lowenstern; John K Forrest; Yousif Ahmad; Michael Cleman; Abdulla Al Damluji; Michael G Nanna
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

2.  Silencing of O-linked N-acetylglucosamine transferase ameliorates hypercalcemia-induced neurotoxicity in renal failure by regulating EZH2/KLF2/CXCL1 axis.

Authors:  Yaochen Cao; Xin Chen; Hongming Sun
Journal:  Cell Death Dis       Date:  2021-08-30       Impact factor: 8.469

3.  A Web-Based, Provider-Driven Mobile App to Enhance Patient Care Coordination Between Dialysis Facilities and Hospitals: Development and Pilot Implementation Study.

Authors:  Laura C Plantinga; Courtney Hoge; Ann E Vandenberg; Kyle James; Tahsin Masud; Anjali Khakharia; Carol Gray; Bernard G Jaar; Janice P Lea; Christopher M O'Donnell; Richard Mutell
Journal:  JMIR Form Res       Date:  2022-06-10

4.  Hospitalization Trajectories and Risks of ESKD and Death in Individuals With CKD.

Authors:  Anand Srivastava; Xuan Cai; Rupal Mehta; Jungwha Lee; David I Chu; Katherine T Mills; Tariq Shafi; Jonathan J Taliercio; Jesse Y Hsu; Sarah J Schrauben; Milda R Saunders; Clarissa J Diamantidis; Chi-Yuan Hsu; Sushrut S Waikar; James P Lash; Tamara Isakova
Journal:  Kidney Int Rep       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.